Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1502 (LINC01502) is a member of the long intergenic non-coding RNA (lincRNA) family, which are autonomously transcribed RNA molecules longer than 200 nucleotides that do not encode proteins and do not overlap any protein-coding genes[1][3]. LINC01502 is identified in the human genome (e.g., NCBI Gene: 100130954, Ensembl: ENSG00000237339)[1]. Like other lincRNAs, LINC01502 is presumed to regulate gene expression, chromatin organization, or transcription, but its specific biological function, disease association, and clinical relevance have not been described in current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1502 (LINC01502).